Detection of circulating tumor cells

Detection of circulating tumor cells in sufferers with breast most cancers utilizing the conditionally reprogrammed cell tradition methodology and reverse transcription-PCR of hTERT and MAGE A1-6

The current research aimed to confirm the efficacy of the conditionally reprogrammed cell (CRC) tradition methodology for the detection of circulating tumor cells (CTCs) in breast most cancers. CTCs have been remoted from the peripheral blood of sufferers with breast most cancers, and tradition of the collected CTCs was carried out in response to the conditional reprogramming protocol.

  • Whole RNA was extracted from cultured CTCs, and the hTERT and MAGE A1-6 genes have been amplified utilizing reverse transcription-PCR (RT-PCR). As well as, RNA extraction from one other blood pattern was carried out and the expression of the 2 genes was analyzed by RT-PCR solely.
  • Following CRC tradition, grown CTCs have been noticed in 7 samples (23.3%). The CTC detection charges by RT-PCR for the hTERT and MAGE A1-6 genes in CTCs grown utilizing the CRC tradition methodology have been 26.7 and 10.0%, respectively.
  • The optimistic expression charges for the hTERT and MAGE genes in CTCs assessed by RT-PCR solely have been 44.1 and 23.5%, respectively. When combining the optimistic expression charges of RT-PCR solely and CRC tradition for the hTERT and MAGE A1-6 genes, CTC detection charges elevated to 53.Three and 23.3%, respectively. Moreover, when combining the optimistic expression charges of the 2 genes by both methodology, the CTC detection price was the best worth noticed.
  • In conclusion, the current research revealed the potential of CRC tradition within the detection of CTCs in breast most cancers. Moreover, a mixture of CRC tradition and RT-PCR for the hTERT and MAGE A1-6 genes is helpful in enhancing the detection price of CTCs within the blood.

oxfordpcs
oxfordpcs
GPR81 antibody
70R-50946 100 ul
EUR 244
Description: Purified Polyclonal GPR81 antibody
GPR81 Antibody
ABD2766 100 ug
EUR 438
GPR81 Antibody
44942-100ul 100ul
EUR 252
GPR81 Antibody
44942-50ul 50ul
EUR 187
GPR81 antibody
20R-GR037 50 ug
EUR 679
Description: Rabbit polyclonal GPR81 antibody
GPR81 antibody
20R-GR038 50 ug
EUR 679
Description: Rabbit polyclonal GPR81 antibody
GPR81 Antibody
DF2766 200ul
EUR 304
Description: GPR81 antibody detects endogenous levels of total GPR81.
Rabbit Polyclonal antibody Anti-CRBN
Anti-CRBN 50 µg
EUR 349
Polyclonal Goat Anti-GPR81 / FKSG80 Antibody
APR16285G 0.1 mg
EUR 484
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-GPR81 / FKSG80 . This antibody is tested and proven to work in the following applications:
GPR81 Conjugated Antibody
C44942 100ul
EUR 397
GPR81 Blocking Peptide
20-abx063821
  • EUR 272.00
  • EUR 411.00
  • 1 mg
  • 5 mg
  • Shipped within 5-10 working days.
GPR81 Blocking Peptide
DF2766-BP 1mg
EUR 195
pDNR-Dual-GPR81
PVT17473 2 ug
EUR 231
Polyclonal GPR81 Antibody (C-term)
APR16611G 0.1ml
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR81 (C-term). This antibody is tested and proven to work in the following applications:
GPR81 ELISA KIT|Human
EF009971 96 Tests
EUR 689
Polyclonal Goat anti-GST α-form
GST-ANTI-1 50 uL
EUR 280
Polyclonal Goat anti-GST μ-form
GST-ANTI-2 50 uL
EUR 280
Polyclonal Goat anti-GST p-form
GST-ANTI-3 50 uL
EUR 280
Polyclonal FKSG80 / GPR81 Antibody (C-Terminus)
APR15995G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (C-Terminus). This antibody is tested and proven to work in the following applications:
Polyclonal FKSG80 / GPR81 Antibody (Extracellular Domain)
APR15996G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (Extracellular Domain). This antibody is tested and proven to work in the following applications:
Polyclonal FKSG80 / GPR81 Antibody (N-Terminus)
APR15997G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (N-Terminus). This antibody is tested and proven to work in the following applications:
G Protein-Coupled Receptor 81 (GPR81) Antibody
20-abx147554
  • EUR 425.00
  • EUR 342.00
  • 100 ug
  • 50 ug
  • Shipped within 5-10 working days.
G Protein-Coupled Receptor 81 (GPR81) Antibody
20-abx008192
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul
  • Shipped within 5-10 working days.
G Protein-Coupled Receptor 81 (GPR81) Antibody
abx028676-400ul 400 ul
EUR 523
  • Shipped within 5-10 working days.
G Protein-Coupled Receptor 81 (GPR81) Antibody
abx028676-80l 80 µl
EUR 286
  • Shipped within 5-10 working days.
G Protein-Coupled Receptor 81 (GPR81) Antibody
abx430538-200ul 200 ul
EUR 384
  • Shipped within 1-3 working days.
G Protein-Coupled Receptor 81 (GPR81) Antibody
abx233610-100ug 100 ug
EUR 551
  • Shipped within 5-12 working days.
Gpr81 ORF Vector (Rat) (pORF)
ORF067824 1.0 ug DNA
EUR 506
Gpr81 ORF Vector (Mouse) (pORF)
ORF046573 1.0 ug DNA
EUR 506
GPR81 sgRNA CRISPR Lentivector set (Human)
K0893201 3 x 1.0 ug
EUR 339
Gpr81 sgRNA CRISPR Lentivector set (Rat)
K6130201 3 x 1.0 ug
EUR 339
Gpr81 sgRNA CRISPR Lentivector set (Mouse)
K3904701 3 x 1.0 ug
EUR 339
GPR81 sgRNA CRISPR Lentivector (Human) (Target 1)
K0893202 1.0 ug DNA
EUR 154
GPR81 sgRNA CRISPR Lentivector (Human) (Target 2)
K0893203 1.0 ug DNA
EUR 154
GPR81 sgRNA CRISPR Lentivector (Human) (Target 3)
K0893204 1.0 ug DNA
EUR 154
Gpr81 sgRNA CRISPR Lentivector (Rat) (Target 1)
K6130202 1.0 ug DNA
EUR 154
Gpr81 sgRNA CRISPR Lentivector (Rat) (Target 2)
K6130203 1.0 ug DNA
EUR 154
Gpr81 sgRNA CRISPR Lentivector (Rat) (Target 3)
K6130204 1.0 ug DNA
EUR 154
Gpr81 sgRNA CRISPR Lentivector (Mouse) (Target 1)
K3904702 1.0 ug DNA
EUR 154
Gpr81 sgRNA CRISPR Lentivector (Mouse) (Target 2)
K3904703 1.0 ug DNA
EUR 154
Gpr81 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K3904704 1.0 ug DNA
EUR 154
GPR81 Protein Vector (Rat) (pPB-C-His)
PV271294 500 ng
EUR 603
GPR81 Protein Vector (Rat) (pPB-N-His)
PV271295 500 ng
EUR 603
GPR81 Protein Vector (Rat) (pPM-C-HA)
PV271296 500 ng
EUR 603
GPR81 Protein Vector (Rat) (pPM-C-His)
PV271297 500 ng
EUR 603
GPR81 Protein Vector (Mouse) (pPB-C-His)
PV186290 500 ng
EUR 603
GPR81 Protein Vector (Mouse) (pPB-N-His)
PV186291 500 ng
EUR 603
GPR81 Protein Vector (Mouse) (pPM-C-HA)
PV186292 500 ng
EUR 603
GPR81 Protein Vector (Mouse) (pPM-C-His)
PV186293 500 ng
EUR 603
Gpr81 3'UTR Luciferase Stable Cell Line
TU205392 1.0 ml Ask for price
Gpr81 3'UTR GFP Stable Cell Line
TU159042 1.0 ml Ask for price
GPR81 3'UTR Luciferase Stable Cell Line
TU009183 1.0 ml
EUR 1521
Gpr81 3'UTR Luciferase Stable Cell Line
TU109042 1.0 ml Ask for price
GPR81 3'UTR GFP Stable Cell Line
TU059183 1.0 ml
EUR 1521
Gpr81 3'UTR GFP Stable Cell Line
TU255392 1.0 ml Ask for price
GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
K0893205 3 x 1.0 ug
EUR 376
Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
K6130205 3 x 1.0 ug
EUR 376
Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
K3904705 3 x 1.0 ug
EUR 376
GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
K0893206 1.0 ug DNA
EUR 167
GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
K0893207 1.0 ug DNA
EUR 167
GPR81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
K0893208 1.0 ug DNA
EUR 167
Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
K6130206 1.0 ug DNA
EUR 167
Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
K6130207 1.0 ug DNA
EUR 167
Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
K6130208 1.0 ug DNA
EUR 167
Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
K3904706 1.0 ug DNA
EUR 167
Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
K3904707 1.0 ug DNA
EUR 167
Gpr81 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)
K3904708 1.0 ug DNA
EUR 167
Anti-Anti-SEPT2 Antibody antibody
STJ28365 100 µl
EUR 277
Anti-Anti-SEPT7 Antibody antibody
STJ28963 100 µl
EUR 277
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19.
Anti-Anti-SEPT6 antibody antibody
STJ11100949 100 µl
EUR 277
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined.
Anti-Anti-SEPT2 Antibody antibody
STJ25475 100 µl
EUR 277
Anti-Anti-SEPT5 Antibody antibody
STJ25477 100 µl
EUR 277
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced.
Anti-Anti-SEPT8 Antibody antibody
STJ25479 100 µl
EUR 277
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Anti-Anti-SEPT9 Antibody antibody
STJ111369 100 µl
EUR 277
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.
Anti-Anti-SEPT11 Antibody antibody
STJ111530 100 µl
EUR 277
Anti-Anti-SEPT4 Antibody antibody
STJ112276 100 µl
EUR 277
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer.
Anti-Anti-MARCH9 Antibody antibody
STJ112609 100 µl
EUR 277
Anti-Anti-SEPT11 Antibody antibody
STJ113941 100 µl
EUR 277
Anti-Anti-SEPT11 Antibody antibody
STJ114081 100 µl
EUR 277
Anti-Anti-SEPT5 Antibody antibody
STJ114819 100 µl
EUR 277
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced.
Anti-Anti-MARCH8 Antibody antibody
STJ114828 100 µl
EUR 277
Anti-Anti-MARCH6 Antibody antibody
STJ118549 100 µl
EUR 277
Anti-Anti-MARCH6 Antibody antibody
STJ118550 100 µl
EUR 277
Anti-Anti-MARCH7 Antibody antibody
STJ118752 100 µl
EUR 277
Anti-Anti-SEPT3 Antibody antibody
STJ118990 100 µl
EUR 277
Anti-Anti-SEPT1 antibody antibody
STJ119580 100 µl
EUR 277
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012]
Anti-Anti-SEPT7 Antibody antibody
STJ116214 100 µl
EUR 277
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19.
Anti-Anti-SEPT8 Antibody antibody
STJ117206 100 µl
EUR 277
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Anti-Anti-SEPT12 Antibody antibody
STJ117759 100 µl
EUR 277
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene.
Anti-Anti-DDB1 Antibody
A00333 100uL
EUR 455
Description: Rabbit Polyclonal DDB1 Antibody. Validated in IP and tested in Human, Mouse.
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
AEA465Hu-10x96wellstestplate 10x96-wells test plate
EUR 5647.8
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Intra-Assay: CV<10%
  • Int
  • Show more
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
AEA465Hu-1x48wellstestplate 1x48-wells test plate
EUR 552.76
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Intra-Assay: CV<10%
  • Int
  • Show more
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
AEA465Hu-1x96wellstestplate 1x96-wells test plate
EUR 746.8
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Intra-Assay: CV<10%
  • Int
  • Show more
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
AEA465Hu-5x96wellstestplate 5x96-wells test plate
EUR 3060.6
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Intra-Assay: CV<10%
  • Int
  • Show more
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
4-AEA465Hu
  • EUR 5698.00
  • EUR 3011.00
  • EUR 747.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
  • Known also as Anti-Sperm Antibody elisa. Alternative names of the recognized antigen: Anti-Spermatozoa Antibodies
  • Sperm Antibodies
  • Antisperm Antibodies
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species.
ELISA kit for Human Anti-AsAb (Anti-Anti-Sperm Antibody Antibody)
ELK8071 1 plate of 96 wells
EUR 432
  • The microtiter plate provided in this kit has been pre-coated with an antigen. Standards or samples are then added to the appropriate microtiter plate wells with a Horseradish Peroxidase (HRP)-conjugated secondary antibody. After TMB substrate soluti
  • Show more
Description: A competitive Inhibition ELISA kit for detection of Anti-Anti-Sperm Antibody Antibody from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.
Anti-HAMA Antibody
E61I006 1mg
EUR 349
anti- ASH2L antibody
FNab00637 100µg
EUR 505.25
  • Immunogen: ash2(absent, small, or homeotic)-like(Drosophila)
  • Uniprot ID: Q9UBL3
  • Gene ID: 9070
  • Research Area: Epigenetics, Metabolism
Description: Antibody raised against ASH2L
anti- ASIC2 antibody
FNab00638 100µg
EUR 505.25
  • Recommended dilution: WB: 1:200-1:1000
  • Immunogen: amiloride-sensitive cation channel 1, neuronal
  • Uniprot ID: Q16515
  • Gene ID: 40
  • Research Area: Neuroscience
Description: Antibody raised against ASIC2
anti- ASIC4 antibody
FNab00639 100µg
EUR 505.25
  • Recommended dilution: WB: 1:200-1:1000
  • Immunogen: amiloride-sensitive cation channel 4, pituitary
  • Uniprot ID: Q96FT7
  • Gene ID: 55515
  • Research Area: Neuroscience
Description: Antibody raised against ASIC4
anti- ASK1 antibody
FNab00640 100µg
EUR 505.25
  • Recommended dilution: WB: 1:100-1:1000
  • Immunogen: mitogen-activated protein kinase kinase kinase 5
  • Uniprot ID: Q99683
  • Gene ID: 4217
  • Research Area: Immunology, Cardiovascular, Metabolism
Description: Antibody raised against ASK1
anti- ASL antibody
FNab00641 100µg
EUR 505.25
  • Recommended dilution: WB: 1:200-1:1000
  • IHC: 1:100-1:500
  • Immunogen: argininosuccinate lyase
  • Uniprot ID: P04424
  • Gene ID: 435
  • Research Area: Metabolism
Description: Antibody raised against ASL
anti- ASMTL antibody
FNab00642 100µg
EUR 505.25
  • Recommended dilution: WB: 1:500 - 1:2000
  • IHC: 1:50 - 1:200
  • IP: 1:50 - 1:200
  • Immunogen: acetylserotonin O-methyltransferase-like
  • Uniprot ID: O95671
  • Gene ID: 8623
  • Research Area: Metabolism
Description: Antibody raised against ASMTL
anti- ASNA1 antibody
FNab00643 100µg
EUR 505.25
  • Recommended dilution: WB: 1:200 - 1:2000
  • IHC: 1:50 - 1:200
  • Immunogen: arsA arsenite transporter, ATP-binding, homolog 1 (bacterial)
  • Uniprot ID: O43681
  • Gene ID: 439
  • Research Area: Metabolism
Description: Antibody raised against ASNA1
anti- ASNS antibody
FNab00644 100µg
EUR 505.25
  • Recommended dilution: WB: 1:500-1:2000
  • IP: 1:500-1:1000
  • Immunogen: asparagine synthetase
  • Uniprot ID: P08243
  • Gene ID: 440
  • Research Area: Metabolism
Description: Antibody raised against ASNS
anti- ASPA antibody
FNab00645 100µg
EUR 505.25
  • Recommended dilution: WB: 1:500-1:1000
  • IHC: 1:50-1:500
  • Immunogen: aspartoacylase(Canavan disease)
  • Uniprot ID: P45381
  • Gene ID: 443
  • Research Area: Metabolism
Description: Antibody raised against ASPA


Incidence, scientific course and threat issue for recurrent PCR positivity in discharged COVID-19 sufferers in Guangzhou, China: A potential cohort research

The phenomenon of COVID-19 sufferers examined optimistic for SARS-CoV-2 after discharge (redetectable as optimistic, RP) emerged globally. The information of incidence price and threat elements for RP occasion and the scientific options of RP sufferers might present suggestions for virus containment and circumstances administration for COVID-19.

We prospectively collected and analyzed the epidemiological, scientific and virological information from 285 grownup sufferers with COVID-19 and bought their particular scientific final result (getting PCR optimistic or not throughout post-discharge surveillance). By March 10, 27 (9.5%) discharged sufferers had examined optimistic for SARS-CoV-2 of their nasopharyngeal swab after a median length of seven·Zero days (IQR 5·0-8·0).

In comparison with first admission, RP sufferers typically had milder scientific signs, decrease viral load, shorter size of keep and improved pulmonary circumstances at readmission (p<0.05). Elder RP sufferers (≥ 60 years previous) have been extra prone to be symptomatic in comparison with youthful sufferers (7/8, 87.5% vs. 3/19, 18.8%, p = 0.001) at readmission.

Age, intercourse, epidemiological historical past, scientific signs and underlying illnesses have been related between RP and non-RP sufferers (p>0.05). A protracted length of viral shedding (>10 days) throughout the first hospitalization [adjusted odds ratio [aOR]: 5.82, 95% confidence interval [CI]: 2.50-13.57 for N gene; aOR: 9.64, 95% CI: 3.91-23.73 for ORF gene] and better Ct worth (ORF) within the third week of the primary hospitalization (aOR: 0.69; 95% CI: 0.50-0.95) have been related to RP occasions.

In conclusion, RP occasions occurred in practically 10% of COVID-19 sufferers shortly after the detrimental checks, weren’t related to worsening signs and unlikely mirror reinfection. Sufferers’ lack of effectivity in virus clearance was a threat issue for RP end result. It’s noteworthy that elder RP sufferers (≥ 60 years previous) have been extra vulnerable to scientific signs at readmission.

Ovine Paratuberculosis: Seroprevalence and comparability of fecal tradition and direct fecal PCR assay

Johne’s illness is persistent, incurable illness, brought on by Mycobacterium avium subsp. paratuberculosis (MAP). Most research in Egypt targeted on incidence of the illness in cattle however few research have been reported presence of antibodies towards MAP in sheep. The current research decided the seroprevalence price of MAP amongst sheep in 4 Governorates and assessed the related threat elements to MAP-infection.

  • The seroprevalence price of MAP amongst sheep was non-significant various between totally different Governorates, it was ranged between 3.75%-12.3%. The outcomes revealed that the seroprevalence price of the illness was considerably elevated in diarrheic sheep (11 %, 95 %CI: 7.2-16.2) throughout spring (15 %, 95 %CI: 8.3-25) and summer time (8%, 95 %CI: 4.13-13.8) seasons.
  • Opposite, the age of sheep and make contact with with different ruminants like cattle or goats had non-significant impact of spreading of MAP-infection amongst sheep. The detection of MAP in feces of sheep was carried out utilizing tradition and PCR to find out the effectivity of each checks.
  • The kappa check revealed good settlement between each checks for detection of MAP. The obtained discovering confirms the presence of MAP amongst sheep in Egypt. So, the suitable management measures ought to be taken to scale back spreading of the illness amongst sheep and cut back its financial losses.

Acrosin Blocking Peptide

AF9003-BP 1mg
EUR 195

AIFL Blocking Peptide

AF9005-BP 1mg
EUR 195

AMPKgamma2 Blocking Peptide

AF9006-BP 1mg
EUR 195

ANKRD20 Blocking Peptide

AF9008-BP 1mg
EUR 195

APOBEC3A Blocking Peptide

AF9009-BP 1mg
EUR 195

ApoOL Blocking Peptide

AF9010-BP 1mg
EUR 195

ARHGAP1 Blocking Peptide

AF9011-BP 1mg
EUR 195

ARHGAP22 Blocking Peptide

AF9012-BP 1mg
EUR 195

ARHGEF19 Blocking Peptide

AF9013-BP 1mg
EUR 195

ARMCX1 Blocking Peptide

AF9014-BP 1mg
EUR 195

Arrdc1 Blocking Peptide

AF9016-BP 1mg
EUR 195

ARRDC2 Blocking Peptide

AF9017-BP 1mg
EUR 195

Arrdc4 Blocking Peptide

AF9018-BP 1mg
EUR 195

ASF1B Blocking Peptide

AF9022-BP 1mg
EUR 195

BAM32 Blocking Peptide

AF9023-BP 1mg
EUR 195

BEGAIN Blocking Peptide

AF9024-BP 1mg
EUR 195

BRD3 Blocking Peptide

AF9025-BP 1mg
EUR 195

BTBD6 Blocking Peptide

AF9026-BP 1mg
EUR 195

Cables2 Blocking Peptide

AF9029-BP 1mg
EUR 195

CaMKIbeta Blocking Peptide

AF9031-BP 1mg
EUR 195

CAS Blocking Peptide

AF9032-BP 1mg
EUR 195

CD158f2 Blocking Peptide

AF9037-BP 1mg
EUR 195

CD32 Blocking Peptide

AF9038-BP 1mg
EUR 195

Cdc16 Blocking Peptide

AF9039-BP 1mg
EUR 195

Centrobin Blocking Peptide

AF9040-BP 1mg
EUR 195

CEP152 Blocking Peptide

AF9041-BP 1mg
EUR 195

CMTM4 Blocking Peptide

AF9042-BP 1mg
EUR 195

CNOT2 Blocking Peptide

AF9043-BP 1mg
EUR 195

COL19A1 Blocking Peptide

AF9044-BP 1mg
EUR 195

COL4A6 Blocking Peptide

AF9045-BP 1mg
EUR 195

COL5A3 Blocking Peptide

AF9046-BP 1mg
EUR 195

CRSP130 Blocking Peptide

AF9049-BP 1mg
EUR 195

CYB561D1 Blocking Peptide

AF9050-BP 1mg
EUR 195

CYP4F2 Blocking Peptide

AF9051-BP 1mg
EUR 195

Eg5 Blocking Peptide

AF9058-BP 1mg
EUR 195

Eps8L3 Blocking Peptide

AF9061-BP 1mg
EUR 195

eRF3a Blocking Peptide

AF9062-BP 1mg
EUR 195

ETL Blocking Peptide

AF9063-BP 1mg
EUR 195

FAM80B Blocking Peptide

AF9064-BP 1mg
EUR 195

FBP3 Blocking Peptide

AF9065-BP 1mg
EUR 195

FoxR1 Blocking Peptide

AF9067-BP 1mg
EUR 195

GAAP Blocking Peptide

AF9068-BP 1mg
EUR 195

GALR3 Blocking Peptide

AF9069-BP 1mg
EUR 195

GAS3 Blocking Peptide

AF9070-BP 1mg
EUR 195

GBP4 Blocking Peptide

AF9071-BP 1mg
EUR 195

GPR124 Blocking Peptide

AF9073-BP 1mg
EUR 195

GPR139 Blocking Peptide

AF9074-BP 1mg
EUR 195

GPR41 Blocking Peptide

AF9075-BP 1mg
EUR 195

GPR50 Blocking Peptide

AF9076-BP 1mg
EUR 195

GPRC5C Blocking Peptide

AF9077-BP 1mg
EUR 195

Grap Blocking Peptide

AF9079-BP 1mg
EUR 195

GRB10 Blocking Peptide

AF9080-BP 1mg
EUR 195

GRIN2 Blocking Peptide

AF9081-BP 1mg
EUR 195

GS28 Blocking Peptide

AF9082-BP 1mg
EUR 195

HABP2 Blocking Peptide

AF9083-BP 1mg
EUR 195

HORMAD1 Blocking Peptide

AF9088-BP 1mg
EUR 195

HoxD10 Blocking Peptide

AF9089-BP 1mg
EUR 195

HoxD8 Blocking Peptide

AF9090-BP 1mg
EUR 195

HRT2 Blocking Peptide

AF9092-BP 1mg
EUR 195

INTS2 Blocking Peptide

AF9098-BP 1mg
EUR 195

KCNT1 Blocking Peptide

AF9099-BP 1mg
EUR 195

KIF13B Blocking Peptide

AF9100-BP 1mg
EUR 195

KIR3.1 Blocking Peptide

AF9101-BP 1mg
EUR 195

KIR3.4 Blocking Peptide

AF9102-BP 1mg
EUR 195

LHR Blocking Peptide

AF9104-BP 1mg
EUR 195

LONP2 Blocking Peptide

AF9105-BP 1mg
EUR 195

LRP10 Blocking Peptide

AF9106-BP 1mg
EUR 195

LUC7L2 Blocking Peptide

AF9107-BP 1mg
EUR 195

Matriptase Blocking Peptide

AF9109-BP 1mg
EUR 195

MCT12 Blocking Peptide

AF9110-BP 1mg
EUR 195

ME2 Blocking Peptide

AF9111-BP 1mg
EUR 195

MINK1 Blocking Peptide

AF9112-BP 1mg
EUR 195

Mob3C Blocking Peptide

AF9114-BP 1mg
EUR 195

MPP1 Blocking Peptide

AF9115-BP 1mg
EUR 195

MRCKbeta Blocking Peptide

AF9116-BP 1mg
EUR 195

MRGF Blocking Peptide

AF9117-BP 1mg
EUR 195

NDUFS5 Blocking Peptide

AF9124-BP 1mg
EUR 195

Nek9 Blocking Peptide

AF9125-BP 1mg
EUR 195

NFATc2IP Blocking Peptide

AF9128-BP 1mg
EUR 195

NFRKB Blocking Peptide

AF9129-BP 1mg
EUR 195

Nicalin Blocking Peptide

AF9130-BP 1mg
EUR 195

Nidogen Blocking Peptide

AF9131-BP 1mg
EUR 195

NIPA Blocking Peptide

AF9132-BP 1mg
EUR 195

NMUR1 Blocking Peptide

AF9133-BP 1mg
EUR 195

Nox3 Blocking Peptide

AF9134-BP 1mg
EUR 195

NRIP3 Blocking Peptide

AF9135-BP 1mg
EUR 195

OMG Blocking Peptide

AF9146-BP 1mg
EUR 195

OTUB2 Blocking Peptide

AF9147-BP 1mg
EUR 195

Oxr1 Blocking Peptide

AF9148-BP 1mg
EUR 195

PDE10A Blocking Peptide

AF9150-BP 1mg
EUR 195

PEG3 Blocking Peptide

AF9152-BP 1mg
EUR 195

Peropsin Blocking Peptide

AF9153-BP 1mg
EUR 195

PHF3 Blocking Peptide

AF9154-BP 1mg
EUR 195

PHKB Blocking Peptide

AF9156-BP 1mg
EUR 195

PIG3 Blocking Peptide

AF9159-BP 1mg
EUR 195

PIPOX Blocking Peptide

AF9160-BP 1mg
EUR 195

PLA1A Blocking Peptide

AF9162-BP 1mg
EUR 195

Pmp24 Blocking Peptide

AF9163-BP 1mg
EUR 195

PNPase Blocking Peptide

AF9164-BP 1mg
EUR 195

POLR3B Blocking Peptide

AF9165-BP 1mg
EUR 195

POLR3E Blocking Peptide

AF9166-BP 1mg
EUR 195

PRPF31 Blocking Peptide

AF9169-BP 1mg
EUR 195

QSK Blocking Peptide

AF9172-BP 1mg
EUR 195

RAB3IP Blocking Peptide

AF9176-BP 1mg
EUR 195

Rabr Blocking Peptide

AF9177-BP 1mg
EUR 195

RBM34 Blocking Peptide

AF9179-BP 1mg
EUR 195

RCC2 Blocking Peptide

AF9180-BP 1mg
EUR 195

RFX3 Blocking Peptide

AF9181-BP 1mg
EUR 195

RHOBTB3 Blocking Peptide

AF9183-BP 1mg
EUR 195

Rim4 Blocking Peptide

AF9186-BP 1mg
EUR 195

RREB1 Blocking Peptide

AF9187-BP 1mg
EUR 195

RTCD1 Blocking Peptide

AF9190-BP 1mg
EUR 195

RXRgamma Blocking Peptide

AF9191-BP 1mg
EUR 195

SCAF1 Blocking Peptide

AF9193-BP 1mg
EUR 195

SCAND1 Blocking Peptide

AF9194-BP 1mg
EUR 195

Separase Blocking Peptide

AF9195-BP 1mg
EUR 195

SH3BGR Blocking Peptide

AF9198-BP 1mg
EUR 195

Sin3B Blocking Peptide

AF9199-BP 1mg
EUR 195

SphK2 Blocking Peptide

AF9201-BP 1mg
EUR 195

STAM2 Blocking Peptide

AF9203-BP 1mg
EUR 195

StIp1 Blocking Peptide

AF9204-BP 1mg
EUR 195

SUHW1 Blocking Peptide

AF9205-BP 1mg
EUR 195

SYT Blocking Peptide

AF9206-BP 1mg
EUR 195

TAB182 Blocking Peptide

AF9207-BP 1mg
EUR 195

TAUT Blocking Peptide

AF9208-BP 1mg
EUR 195

TBL2 Blocking Peptide

AF9209-BP 1mg
EUR 195

TBX2 Blocking Peptide

AF9210-BP 1mg
EUR 195

TCFL5 Blocking Peptide

AF9211-BP 1mg
EUR 195

TDE1 Blocking Peptide

AF9212-BP 1mg
EUR 195

TIS11B Blocking Peptide

AF9213-BP 1mg
EUR 195

TLE4 Blocking Peptide

AF9214-BP 1mg
EUR 195

TMC8 Blocking Peptide

AF9215-BP 1mg
EUR 195

TOB1 Blocking Peptide

AF9216-BP 1mg
EUR 195

TRF1 Blocking Peptide

AF9217-BP 1mg
EUR 195

TUTase Blocking Peptide

AF9219-BP 1mg
EUR 195

Uba5 Blocking Peptide

AF9220-BP 1mg
EUR 195

UBE3B Blocking Peptide

AF9221-BP 1mg
EUR 195

USP36 Blocking Peptide

AF9223-BP 1mg
EUR 195

USP40 Blocking Peptide

AF9224-BP 1mg
EUR 195

USP50 Blocking Peptide

AF9225-BP 1mg
EUR 195

V1RL3 Blocking Peptide

AF9226-BP 1mg
EUR 195

Vav2 Blocking Peptide

AF9228-BP 1mg
EUR 195

WAVE1 Blocking Peptide

AF9229-BP 1mg
EUR 195

WAVE4 Blocking Peptide

AF9230-BP 1mg
EUR 195

WBSCR11 Blocking Peptide

AF9231-BP 1mg
EUR 195